Home

Versant Venture Capital V (Canada), LP

CIK 1612235 · last filed 2021-02-18

Versant Venture Capital V (Canada), LP is a corporate insider who has filed 5 SEC Form 4 insider transactions across 3 companies since 2016. The most recent filing, for RPTX, was dated Feb 18, 2021. Across all open-market trades the lifetime net is +$63.5M, making them a net buyer over the disclosed history. The firm reports its address in San Francisco, CA. 28 SEC filings were submitted jointly with Versant Venture Capital V, L.P.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$0

Companies

3

Total Filings

5

Lifetime Open-Market Net

$63.52M

Filer Profile

Reported Address
ONE SANSOME STREET
SUITE 1650
SAN FRANCISCO, CA 94104
Phone
(650) 233-7877
State of Incorporation
Ontario, Canada
Related Filers
Versant Venture Capital V, L.P. — 28 joint filings, latest 2025-08-12
Versant Affiliates Fund V, L.P. — 27 joint filings, latest 2025-08-12
Versant Ophthalmic Affiliates I, L.P. — 27 joint filings, latest 2025-08-12
Versant Ventures V, LLC — 19 joint filings, latest 2025-08-12
Versant Ventures V (Canada), L.P. — 18 joint filings, latest 2025-08-12
Versant Ventures V GP-GP (Canada), Inc. — 15 joint filings, latest 2025-08-12
Versant Venture Capital VI, L.P. — 10 joint filings, latest 2022-06-07
Versant Ventures VI GP, L.P. — 10 joint filings, latest 2022-06-07
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
Repare Therapeutics Inc. (RPTX) Delisted 10%+ Owner 63,619 $2.65 $168.6K $50.00M 2 2021-02-18
CRNX 10%+ Owner 0 $84.95 $0 $0 2 2019-02-06
CRISPR Therapeutics AG (PZRX) Delisted 10%+ Owner 4,008,449 — — $13.52M 1 2016-12-23

Recent Filings

5 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2021-02-18 Repare Therapeutics Inc. (RPTX) Delisted Other (J) −3,500,000 $0 EDGAR
2020-06-25 Repare Therapeutics Inc. (RPTX) Delisted Mixed +64,953,490 $50.00M EDGAR
2019-02-06 CRNX Other (J) −3,045,528 $0 EDGAR
2018-07-20 CRNX Conv (C) +13,537,104 $0 EDGAR
2016-12-23 CRISPR Therapeutics AG (PZRX) Delisted Mixed +40,018,194 $13.52M EDGAR
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.